Kisspeptins inhibit ectopic endometrial cell invasion and angiogenesis by suppressing PI3K/AKT signaling pathway via CREB5 in endometriosis

article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-08

Kisspeptins inhibit endometrial cell invasion and angiogenesis in endometriosis by increasing CREB5, which suppresses PI3K/AKT signaling.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09

This study compared transcriptomes from ectopic endometrium and eutopic endometrium from five ovarian endometriosis patients, with eutopic endometrium from three non-endometriosis controls, using RNA sequencing and differential expression analyses to identify progressively altered genes during disease development. KEGG enrichment of these progressive differentially expressed genes highlighted the PI3K/AKT signaling pathway, and the authors focused on the KISS1/KISS1R axis and its proposed upstream regulator CREB5. In animal transplantation models and endometrial cell assays, KISS1/KISS1R reportedly inhibited ectopic endometrial cell invasion and angiogenesis by reducing PI3K and AKT phosphorylation through CREB5, alongside CREB5 knockdown experiments supporting the mechanism. A major limitation explicitly reflected in the design is the small cohort size (five cases and three controls) used for the transcriptomic profiling. This paper is centrally about endometriosis — it investigates how kisspeptins inhibit ectopic endometrial invasion and angiogenesis via the CREB5/PI3K/AKT pathway in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis (EMs) is a common gynecological disorder. According to the most widely recognized theory of retrograde menstruation, endometrial cells require completion of three key steps during ectopic implantation: adhesion, invasion, and angiogenesis. Although kisspeptin exerts anti-invasive and anti-angiogenic effects in multiple tumors, its potential inhibitory effects mediated through the KISS1 receptor (KISS1R) on EMs-related invasion and angiogenesis remain uncharacterized. This study aimed to identify regulatory genes in EMs pathogenesis via RNA sequencing and elucidate underlying molecular mechanisms. We performed a comparative transcriptomic analysis of ectopic endometrium (EC) and eutopic endometrium (EU) in 5 patients with EMs and control endometrium in 3 women without EMs. Then, we screened for genes that showed significant differences between EU and group, and even more pronounced differences between EC and EU, indicating a progressive change. Moreover, we identified the top 20 progressively altered genes during EMs development, including KISS1R. Furthermore, KEGG pathway analysis revealed that these progressively altered DEGs were mainly enriched in the phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) signaling pathway. Previous studies suggest that the PI3K/AKT signaling pathway may mediate cell invasion and angiogenesis in EMs. Additionally, substantial evidence indicates that cAMP-response element binding protein (CREB5), a transcriptional regulator, can regulate the PI3K/AKT pathway. However, the mechanism of functional changes of CREB5 and PI3K/AKT in EMs is unclear. Our study validated the functional role of KISS1/KISS1R in EMs through animal experiments and cell experiments. It may suppress the cell invasion and angiogenesis of endometrial cells by reducing the phosphorylation levels of PI3K and AKT mediated by increasing CREB5. This mechanistic insight provides novel pathogenic explanations for EMs.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A Cyclic AMP Response Element-Binding Protein A

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-06-12T06:09:51.019110+00:00
License: CC0 · commercial use OK